Aprea Therapeutics APRE
NASDAQ APRE
$0.76 +0.01 (+1.29%)
As of: Oct 1, 2026 · 3:38 PM EDT

Aprea Therapeutics (APRE) Other financing activities (2019)

Updated

Aprea Therapeutics (APRE) reported Other financing activities of $3.62 million for Q3 2019, up 730.6% from the prior quarter.

Analysis

Aprea Therapeutics (APRE) Other financing activities (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Aprea Therapeutics 40.11 Mn 40.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 3.62 Mn
Jun 30, 2019 435,798.00
Mar 31, 2019 188,826.00
API Access

Aprea Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=APRE&period=max&api_key=YOUR_API_KEY